CytoDyn Inc. Deferred Tax Assets, Operating Loss Carryforwards
CytoDyn Inc. (CYDY) had Deferred Tax Assets, Operating Loss Carryforwards of $102.73 million as of 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-08-31
- 2026-05-31: Deferred Tax Assets, Operating Loss Carryforwards $102.73M.
- 2025-05-31: Deferred Tax Assets, Operating Loss Carryforwards $97.63M.
- 2024-05-31: Deferred Tax Assets, Operating Loss Carryforwards $100.90M.
- 2023-05-31: Deferred Tax Assets, Operating Loss Carryforwards $96.34M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-05-31 | $102.73M 10-K · filed 2026-08-31 | |
| 2025-05-31 | $97.63M 10-K · filed 2026-08-31 | |
| 2024-05-31 | $100.90M S-1 · filed 2026-04-22 | |
| 2023-05-31 | $96.34M 10-K · filed 2024-08-15 | |
| 2022-05-31 | $106.97M 10-K · filed 2023-09-14 | |
| 2021-05-31 | $74.26M 10-K · filed 2022-08-15 | |
| 2020-05-31 | $55.62M 10-K · filed 2021-07-30 | $55.62M 10-K · filed 2020-08-14 |
| 2019-05-31 | $40.00M 10-K · filed 2020-08-14 | |
| 2018-05-31 | $29.23M 10-K · filed 2019-08-14 | |
| 2017-05-31 | $32.53M 10-K · filed 2018-07-27 | |
| 2016-05-31 | $23.51M 10-K · filed 2017-07-20 | |
| 2015-05-31 | $16.86M 10-K · filed 2016-07-19 | |
| 2014-05-31 | $9.96M 10-K · filed 2015-07-10 | |
| 2013-05-31 | $8.26M 10-K · filed 2014-07-10 | |
| 2012-05-31 | $6.32M 10-K · filed 2013-08-29 |